UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000036950 |
|---|---|
| Receipt number | R000041884 |
| Scientific Title | Japan-Dialysis Outcomes and Practice Patterns Study, 2019-2022 (J-DOPPS7) |
| Date of disclosure of the study information | 2019/06/17 |
| Last modified on | 2023/02/03 15:46:24 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Japan-Dialysis Outcomes and Practice Patterns Study, 2019-2022 (J-DOPPS7)
Acronym
Japan-Dialysis Outcomes and Practice Patterns Study 7 (J-DOPPS7)
Scientific Title
Japan-Dialysis Outcomes and Practice Patterns Study, 2019-2022 (J-DOPPS7)
Scientific Title:Acronym
Japan-Dialysis Outcomes and Practice Patterns Study 7 (J-DOPPS7)
Region
| Japan |
Condition
Condition
End Stage Renal Disease
Classification by specialty
| Nephrology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
J-DOPPS is a part of the Worldwide-DOPPS (DOPPS), an international collaborative research.
The purpose of DOPPS is to investigate and compare the hemodialysis treatment around the world, and to examine the factors that influence the outcome, such as survival rate and quality of life of hemodialysis patients.
It is to collect the data of actual condition of hemodialysis treatent in Japan and to provide them to DOPPS research preside; the purpose of DOPPS is achieved by the cooperation of several countries in the world.
Basic objectives2
Others
Basic objectives -Others
Survey of hemodialysis treatment
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Survey of hemodialysis treatment
(Mortality,Hospitalization, Vascular access,QOL)
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
18 years of age or older and receiving chronic in-center hemodialysis for the treatment of chronic kidney failure.
Key exclusion criteria
1.Patients who receive other blood purification treatment than hemodialysis
2.Patients who receive in-home dialysis
3.Patients who receive hemodialysis for acute renal failure
Target sample size
1440
Research contact person
Name of lead principal investigator
| 1st name | Tadao |
| Middle name | |
| Last name | Akizawa |
Organization
The Kidney Foundation, Japan.
Division name
President
Zip code
102-0074
Address
3-2-7 Kudan-minami,Chiyoda-ku,Tokyo
TEL
03-6910-0588
dopps@flexibleinc.jp
Public contact
Name of contact person
| 1st name | Yoshihiro |
| Middle name | |
| Last name | Ishihara |
Organization
Flexible,Inc.
Division name
J-DOPPS helpdesk
Zip code
150-0043
Address
1-19-11,Dogenzaka,Shibuya-ku,Tokyo
TEL
03-6455-3085
Homepage URL
dopps@flexibleinc.jp
Sponsor or person
Institute
The Kidney Foundation, Japan.
Institute
Department
Personal name
Funding Source
Organization
Astellas Pharma Inc.
ONO PHARMACEUTICAL CO., LTD.
Kissei Pharmaceutical Co., Ltd.
Kyowa Kirin Co., Ltd.
Bayer Yakuhin, Ltd
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
HURECS
Address
2-2-1,Kyobashi,Chuo-ku,Tokyo
Tel
03-5213-0028
dopps@flexibleinc.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 06 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
1532
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2018 | Year | 11 | Month | 19 | Day |
Date of IRB
| 2019 | Year | 01 | Month | 28 | Day |
Anticipated trial start date
| 2019 | Year | 06 | Month | 15 | Day |
Last follow-up date
| 2022 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
| 2022 | Year | 09 | Month | 30 | Day |
Date trial data considered complete
Date analysis concluded
Other
Other related information
none
Management information
Registered date
| 2019 | Year | 06 | Month | 04 | Day |
Last modified on
| 2023 | Year | 02 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041884
